Trimethoprim-Sulfamethoxazole is no longer effective for uncomplicated UTIs.
January 1
There's lots of talk about the increasing resistance of E. coli to TMP-SMX (Bactrim, Septra, etc). But in many areas, E. coli is still susceptible to TMP-SMX. Nevertheless, many clinicians are automatically reaching for quinolones...even in areas with little resistance.
Now experts are concerned about quinolones being overused for uncomplicated urinary tract infections (UTIs). In fact, quinolone resistance is on the rise in some areas.
TMP-SMX is still preferred for uncomplicated UTIs...UNLESS local resistance is higher than 20%.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote